 Visit the TF Network Sites · Institutional Investor Center · Individual Investor Center |
| Download Plug-In |
| Real
Player 8 Basic Windows Media Player |
| Other Conference Calls |
| Other May 15 Calls Today's Calls |
| Call Details | |||
| Cardiogenesis Corporation Earnings Conference Call (Q1 2008) Thu, May 15, 2008, 12:00 pm Eastern
| |||
| About Cardiogenesis Corporation (Other OTC:CGCP.PK) | |||
| Cardiogenesis Corporation, together with its subsidiaries, designs, develops, and distributes laser-based surgical products and disposable fiber-optic accessories for the treatment of ischemia associated with advanced cardiovascular disease through laser myocardial revascularization. The company’s products include transmyocardial revascularization system, which consists of a laser console and a line of fiber-optic, as well as laser-based surgical tools that deliver laser energy from the source laser base unit to the distal tip of the surgical handpiece. Its products also include Port Enabled Angina Relief using Laser Thoracoscopic 8.0 minimally invasive delivery system, which is used for the treatment of chronic severe angina in patients who are not candidates for traditional revascularization. In addition, the company’s products include Phoenix Combination Delivery system that combines the delivery of its Holmium, a YAG TMR therapy with the delivery of biologic or pharmacologic agents to optimize the physiologic and clinical response. Further, its products include Percutaneous Myocardial Channeling procedure/system, through which a laser transmitting catheter is threaded up from the femoral artery at the top of the leg into the heart chamber, where channels are created in the inner portion of the heart muscle. The company markets its products for sale primarily in the United States, Canada, Europe, and Asia. Cardiogenesis Corporation was founded in 1989 and is headquartered in Irvine, California. | |||
More Info: | |||
